All Stories

  1. Stress, Spirituality, and Altruism of Brazilian Medical Students during the COVID-19 Pandemic: A Cross-sectional Analysis
  2. Gut microbiota composition correlates with disease severity in myelodysplastic syndrome
  3. Animal Model of Neonatal Immune Challenge by Lipopolysaccharide: A Study of Sex Influence in Behavioral and Immune/Neurotrophic Alterations in Juvenile Mice
  4. Doxycycline at subantimicrobial dose combined with escitalopram reverses depressive-like behavior and neuroinflammatory hippocampal alterations in the lipopolysaccharide model of depression
  5. Early maternal separation enhances melanoma progression in adult female mice by immune mechanisms
  6. The role of the microbiota-gut-brain axis in neuropsychiatric disorders
  7. Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation?
  8. CCL-11 or Eotaxin-1: An Immune Marker for Ageing and Accelerated Ageing in Neuro-Psychiatric Disorders
  9. A Proline Derivative-Enriched Fraction from Sideroxylon obtusifolium Protects the Hippocampus from Intracerebroventricular Pilocarpine-Induced Injury Associated with Status Epilepticus in Mice
  10. Antidepressants of different classes cause distinct behavioral and brain pro- and anti-inflammatory changes in mice submitted to an inflammatory model of depression
  11. Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: Elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches
  12. The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for bipolar disorder
  13. Phosphodiesterase-5 inhibitors: Shedding new light on the darkness of depression?
  14. Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells
  15. G Protein-Coupled Estrogen Receptor 1 (GPER) as a Novel Target for Schizophrenia Drug Treatment
  16. Bothrops alternatus Snake Venom Induces Cytokine Expression and Oxidative Stress on Renal Function
  17. Thymol reverses depression‐like behaviour and upregulates hippocampal BDNF levels in chronic corticosterone‐induced depression model in female mice
  18. Shared microglial mechanisms underpinning depression and chronic fatigue syndrome and their comorbidities
  19. A Link Between Plasma Microbial Translocation, Microbiome, and Autoantibody Development in First‐Degree Relatives of Systemic Lupus Erythematosus Patients
  20. N-acetylcysteine prevents schizophrenia-like symptoms
  21. Behavioral, affective, and cognitive alterations induced by individual and combined environmental stressors in rats
  22. Antidepressant and Antiaging Effects of Açaí (Euterpe oleracea Mart.) in Mice
  23. Novel insights into the mechanisms underlying depression-associated experimental autoimmune encephalomyelitis
  24. Proconvulsant effects of sildenafil citrate on pilocarpine-induced seizures: Involvement of cholinergic, nitrergic and pro-oxidant mechanisms
  25. Evidence for Host Epigenetic Signatures Arising From Arbovirus Infections: A Systematic Review
  26. Reversal effect of Riparin IV in depression and anxiety caused by corticosterone chronic administration in mice
  27. Leptin Prevents Lipopolysaccharide-Induced Depressive-Like Behaviors in Mice: Involvement of Dopamine Receptors
  28. N-3 polyunsaturated fatty acids and clozapine abrogates poly I: C-induced immune alterations in primary hippocampal neurons
  29. Peritoneal endometriosis induces time-related depressive- and anxiety-like alterations in female rats: involvement of hippocampal pro-oxidative and BDNF alterations
  30. Prevention of pentylenetetrazole-induced kindling and behavioral comorbidities in mice by levetiracetam combined with the GLP-1 agonist liraglutide: Involvement of brain antioxidant and BDNF upregulating properties
  31. Ivabradine possesses anticonvulsant and neuroprotective action in mice
  32. The effect of paroxetine, venlafaxine and bupropion administration alone and combined on spatial and aversive memory performance in rats
  33. Major depression model induced by repeated and intermittent lipopolysaccharide administration: Long-lasting behavioral, neuroimmune and neuroprogressive alterations
  34. Alpha-lipoic acid in the treatment of psychiatric and neurological disorders: a systematic review
  35. Riparin II ameliorates corticosterone-induced depressive-like behavior in mice: Role of antioxidant and neurotrophic mechanisms
  36. Sex influences in behavior and brain inflammatory and oxidative alterations in mice submitted to lipopolysaccharide-induced inflammatory model of depression
  37. Neuroprotective evidence of alpha-lipoic acid and desvenlafaxine on memory deficit in a neuroendocrine model of depression
  38. Antinociceptive activity of Riparin II from Aniba riparia: Further elucidation of the possible mechanisms
  39. Involvement of the dopaminergic system in the antidepressant-like effect of the lectin isolated from the red marine alga Solieria filiformis in mice
  40. Tryptophan catabolites along the indoleamine 2,3-dioxygenase pathway as a biological link between depression and cancer
  41. Advantages of the Alpha-lipoic Acid Association with Chlorpromazine in a Model of Schizophrenia Induced by Ketamine in Rats: Behavioral and Oxidative Stress evidences
  42. IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity
  43. Antimanic activity of minocycline in a GBR12909-induced model of mania in mice: Possible role of antioxidant and neurotrophic mechanisms
  44. Early life experience contributes to the developmental programming of depressive-like behaviour, neuroinflammation and oxidative stress
  45. Effects of standard ethanolic extract from Erythrina velutina in acute cerebral ischemia in mice
  46. The translocator protein (18 kDa) and its role in neuropsychiatric disorders
  47. α-Lipoic Acid as Adjunctive Treatment for Schizophrenia
  48. The interplay between ventro striatal BDNF levels and the effects of valproic acid on the acquisition of ethanol-induced conditioned place preference in mice
  49. Average spectral power changes at the hippocampal electroencephalogram in schizophrenia model induced by ketamine
  50. Brain antioxidant effect of mirtazapine and reversal of sedation by its combination with alpha-lipoic acid in a model of depression induced by corticosterone
  51. Two-hit model of schizophrenia induced by neonatal immune activation and peripubertal stress in rats: Study of sex differences and brain oxidative alterations
  52. Neonatal Immune Challenge with Lipopolysaccharide Triggers Long-lasting Sex- and Age-related Behavioral and Immune/Neurotrophic Alterations in Mice: Relevance to Autism Spectrum Disorders
  53. Impact of the Chronic Omega-3 Fatty Acids Supplementation in Hemiparkinsonism Model Induced by 6-Hydroxydopamine in Rats
  54. Electroencephalographic study of chlorpromazine alone or combined with alpha-lipoic acid in a model of schizophrenia induced by ketamine in rats
  55. HIV antiretroviral drug Efavirenz induces anxiety-like and depression-like behavior in rats: evaluation of neurotransmitter alterations in the striatum
  56. Effects of early or late prenatal immune activation in mice on behavioral and neuroanatomical abnormalities relevant to schizophrenia in the adulthood
  57. Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs
  58. Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness
  59. Telomere length in subjects with schizophrenia, their unaffected siblings and healthy controls: Evidence of accelerated aging
  60. N-acetylcysteine attenuates nicotine-induced kindling in female periadolescent rats
  61. Antidepressant, antioxidant and neurotrophic properties of the standardized extract of Cocos nucifera husk fiber in mice
  62. Evidence for protective effect of lipoic acid and desvenlafaxine on oxidative stress in a model depression in mice
  63. Reversal of corticosterone-induced BDNF alterations by the natural antioxidant alpha-lipoic acid alone and combined with desvenlafaxine: Emphasis on the neurotrophic hypothesis of depression
  64. Antimanic-like activity of candesartan in mice: Possible involvement of antioxidant, anti-inflammatory and neurotrophic mechanisms
  65. Cocos nucifera (L.) (Arecaceae): A phytochemical and pharmacological review
  66. Gender and estrous cycle influences on behavioral and neurochemical alterations in adult rats neonatally administered ketamine
  67. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms
  68. GBR 12909 administration as an animal model of bipolar mania: time course of behavioral, brain oxidative alterations and effect of mood stabilizing drugs
  69. Subchronic administration of riparin III induces antidepressive-like effects and increases BDNF levels in the mouse hippocampus
  70. Antidepressant-like effect of Hoodia gordonii in a forced swimming test in mice: evidence for involvement of the monoaminergic system
  71. Preclinical Evidences for an Antimanic Effect of Carvedilol
  72. Minocycline protects against oxidative damage and alters energy metabolism parameters in the brain of rats subjected to chronic mild stress
  73. Screening for bipolar depression in family medicine practices: Prevalence and clinical correlates
  74. Antifungal Activity of Naphthoquinoidal Compounds In Vitro against Fluconazole-Resistant Strains of Different Candida Species: A Special Emphasis on Mechanisms of Action on Candida tropicalis
  75. Antidepressant-like effect of nitric oxide synthase inhibitors and sildenafil against lipopolysaccharide-induced depressive-like behavior in mice
  76. Major depressive disorder in breast cancer: A critical systematic review of pharmacological and psychotherapeutic clinical trials
  77. Differences in eotaxin serum levels patients with recent onset and in chronic stable schizophrenia: A clue for understanding accelerating aging profile
  78. Synergistic Effect of the Flavonoid Catechin, Quercetin, or Epigallocatechin Gallate with Fluconazole Induces Apoptosis in Candida tropicalis Resistant to Fluconazole
  79. Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: Reversal by clozapine
  80. Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration
  81. N-Acetylcysteine Augmentation to Tranylcypromine in Treatment-Resistant Major Depression
  82. Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways
  83. Affective temperaments and ego defense mechanisms associated with somatic symptom severity in a large sample
  84. Time course of the effects of lipopolysaccharide on prepulse inhibition and brain nitrite content in mice
  85. The Psychological Defensive Profile of Hemodialysis Patients and Its Relationship to Health-Related Quality of Life
  86. Effects of Agomelatine on Oxidative Stress in the Brain of Mice After Chemically Induced Seizures
  87. Effects of lithium on oxidative stress and behavioral alterations induced by lisdexamfetamine dimesylate: Relevance as an animal model of mania
  88. Is there a role for curcumin in the treatment of bipolar disorder?
  89. Augmentation therapy with alpha-lipoic acid and desvenlafaxine: A future target for treatment of depression?
  90. The relationship between affective temperaments, defensive styles and depressive symptoms in a large sample
  91. Angiotensin receptor blockers for bipolar disorder
  92. Synergistic Effects of Amiodarone and Fluconazole on Candida tropicalis Resistant to Fluconazole
  93. Antidepressant Effect of Aminophylline After Ethanol Exposure
  94. Antidepressant Combination Strategies for Major Depressive Disorder
  95. Screening for bipolar disorder in the primary care: A Brazilian survey
  96. Prevention of haloperidol-induced alterations in brain acetylcholinesterase activity by vitamins B co-administration in a rodent model of tardive dyskinesia
  97. Involvement of monoaminergic system in the antidepressant-like effect of riparin I fromAniba riparia(Nees) Mez (Lauraceae) in mice
  98. Effects of alpha-lipoic acid in an animal model of mania induced byd-amphetamine
  99. Antidepressant-like effect ofbis-eugenol in the mice forced swimming test: evidence for the involvement of the monoaminergic system
  100. Differences in vulnerability to nicotine-induced kindling between female and male periadolescent rats
  101. Anticonvulsant effects of agomelatine in mice
  102. Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice
  103. Reversal of cocaine withdrawal-induced anxiety by ondansetron, buspirone and propranolol
  104. Development and validation of the Intrinsic Religiousness Inventory (IRI)
  105. Animal models of prenatal immune challenge and their contribution to the study of schizophrenia: a systematic review
  106. Development and validation of the Intrinsic Religiousness Inventory (IRI)
  107. Anticonvulsant action of Calotropis procera latex proteins
  108. The relationship between religious coping, psychological distress and quality of life in hemodialysis patients
  109. Oxidative Stress and Epilepsy: Literature Review
  110. Validação da versão brasileira da escala de religiosidade de Duke (DUREL)
  111. Anti-inflammatory activities of the hydroalcoholic extracts from Erythrina velutina and E. mulungu in mice
  112. Susceptibility to caspofungin of Candida spp. strains isolated in Ceará, Northeastern Brazil
  113. (−)-α-Bisabolol-induced gastroprotection is associated with reduction in lipid peroxidation, superoxide dismutase activity and neutrophil migration
  114. B vitamins attenuate haloperidol-induced orofacial dyskinesia in rats
  115. Antidepressant-like effect of riparin II fromAniba ripariain mice: evidence for the involvement of the monoaminergic system
  116. Inhibition of ketamine-induced hyperlocomotion in mice by the essential oil of Alpinia zerumbet: possible involvement of an antioxidant effect
  117. Antidepressant-like effect of carvacrol (5-Isopropyl-2-methylphenol) in mice: involvement of dopaminergic system
  118. Ego defense mechanisms in COPD: impact on health-related quality of life and dyspnoea severity
  119. Implications of Efavirenz for Neuropsychiatry: A Review
  120. Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice
  121. Melatonin: Pharmacological Aspects and Clinical Trends
  122. Cocaine-induced status epilepticus and death generate oxidative stress in prefrontal cortex and striatum of mice
  123. Esquizofrenia: uma doença inflamatória?
  124. Effects of isopulegol on pentylenetetrazol-induced convulsions in mice: Possible involvement of GABAergic system and antioxidant activity
  125. Central nervous system effects of the essential oil of the leaves of <I>Alpinia zerumbet</I> in mice
  126. Central nervous system effects of the essential oil of the leaves of Alpinia zerumbet in mice
  127. Gastroprotective activity of isopulegol on experimentally induced gastric lesions in mice: investigation of possible mechanisms of action
  128. Coumarin effects on amino acid levels in mice prefrontal cortex and hippocampus
  129. CSC, an adenosine A2A receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats
  130. Effects of Ethanol or Naltrexone after Ethanol Exposure on Plasma Levels of Hepatic Enzymes, Lipid Profile and Apolipoprotein in Rats
  131. Anticonvulsant activity of hydroalcoholic extracts from Erythrina velutina and Erythrina mulungu
  132. Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats
  133. Differential Effects of Cocaine-Induced Seizures and Lethality on M1-Like Muscarinic and Dopaminergic D1- and D2-Like Binding Receptors in Mice Brain
  134. Cocaine alters catalase activity in prefrontal cortex and striatum of mice
  135. Protective effects of N-acetylserotonin against 6-hydroxydopamine-induced neurotoxicity
  136. Cetamina: aspectos gerais e relação com a esquizofrenia
  137. Effect of anxiolytic, antidepressant, and antipsychotic drugs on cocaine-induced seizures and mortality
  138. Alterations in monoamine levels after cocaine-induced status epilepticus and death in striatum and prefrontal cortex of mice
  139. Effects of ethanol and haloperidol on plasma levels of hepatic enzymes, lipid profile, and apolipoprotein in rats
  140. Central activity of hydroalcoholic extracts from Erythrina velutina and Erythrina mulungu in mice
  141. Cocaine Treatment Causes Early and Long-Lasting Changes in Muscarinic and Dopaminergic Receptors
  142. Effect of one-week ethanol treatment on monoamine levels and dopaminergic receptors in rat striatum
  143. Buspirona aumenta a densidade de receptores dopaminérgicos D2- símile em corpo estriado de rato
  144. Different times of withdrawal from cocaine administration cause changes in muscarinic and dopaminergic receptors in rat premotor cortex
  145. Effects of dopaminergic and cholinergic interactions on rat behavior
  146. Early Withdrawal From Repeated Cocaine Administration Upregulates Muscarinic and Dopaminergic D2-Like Receptors in Rat Neostriatum
  147. Effects of Dopaminergic Agonists and Antagonists on the Muscarinic and Dopaminergic Receptors from Rat Neostriatum